SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

News Shanghai Yizhong Pharmaceutical Co., Ltd.

Equities

688091

CNE1000050F4

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
26.9 ^CNY	+0.71%		-0.26%	-45.36%

Apr. 30	Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	RE
Apr. 29	Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	Apr. 30	RE
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%	Feb. 05	MT
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator	23-10-27	MT
Shanghai Yizhong Pharmaceutical Co., Ltd.(XSSC:688091) added to S&P Global BMI Index	23-09-18	CI
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2023.	23-09-08	CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Chinese Oncology Body Includes Yizhong Pharma's Drug in Non-Small Cell Lung Cancer Treatment Guidelines	23-04-24	MT
Yizhong Pharma Gets Nod to Trial Lung Cancer Drug in China	23-04-17	MT
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-19	CI
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange A Share Index	22-09-09	CI
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange Composite Index	22-09-09	CI
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2022.	22-09-08	CI
Shanghai Yizhong Pharmaceutical’s CFO Steps Down; Successor Named	22-08-18	MT
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-17	CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shanghai Yizhong Pharmaceutical Co., Ltd.

Equities

688091

CNE1000050F4

Summary

Filters